Since GM-CSF employed by several immunotherapeutic approaches such as cancer vaccines and oncolytic viruses [46–48], the aforementioned observations provide important insights into immunobiology of GM-CSF when used as a bolus dose; as opposed to protracted lower-level production locally in a tumor by a viral vector [48]. Here, CSF2 is linked to cancer.